• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL2500078 Tremelimumab注射液 tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-05-20 Medimmune LLC;Astrazeneca Investment (China) Co Ltd view
JXSS2500016 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2025-02-21 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSS2500015 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2025-02-21 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSL2500005 Tremelimumab tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-01-09 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL2500004 Tremelimumab tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-01-09 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL2400249 Tremelimumab注射液 tremelimumab Injection Biological Products(2.2) Import Drug Application 2024-12-25 Medimmune LLC;Astrazeneca Investment (China) Co Ltd view
JXSS2400099 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2024-10-18 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSS2400097 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2024-10-18 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JTS2400031 Tremelimumab原液 tremelimumab Other Biological Products Disposable Import Drug Application 2024-04-13 AstraZeneca AB;Boehringer Ingelheim Pharma Gmbh & Co KG;AstraZeneca Global R&D (China) Co Ltd view
JTS2400032 Tremelimumab注射液 tremelimumab Injection Biological Products Disposable Import Drug Application 2024-04-13 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JTS2400033 Tremelimumab注射液 tremelimumab Injection Biological Products Disposable Import Drug Application 2024-04-13 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSB2300114 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2023-09-23 Vetter Pharma-Fertigung Gmbh & Co KG;Medimmune LLC view
JXSB2300115 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2023-09-23 Vetter Pharma-Fertigung Gmbh & Co KG;Medimmune LLC view
JXSL2200045 Tremelimumab tremelimumab Injection Biological Products(1) Import Drug Application 2022-04-12 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL2200021 Tremelimumab tremelimumab Injection Biological Products(1) Import Drug Application 2022-03-04 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSB2101101 Tremelimumab tremelimumab Injection Biological Products(1) Supplementary Application 2021-12-07 Vetter Pharma-Fertigung Gmbh & Co KG;Medimmune LLC view
JXSB2100010 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2021-02-06 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2021-02-05 view
JXSB2000021 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2020-09-23 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2020-09-22 view
JYSB1900344 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2019-12-18 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2019-12-17 view
JXSL1800076 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2019-01-09 Medimmune LLC In Review 2019-01-08 view